On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
D000595:Amino Acid Sequence; D000818:Animals; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D017951:Antigen Presentation; D001323:Autoantibodies / Q000276:immunology; D001402:B-Lymphocytes / Q000276:immunology; D018984:Epitopes, T-Lymphocyte; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D008213:Lymphocyte Activation; D008969:Molecular Sequence Data; D009157:Myasthenia Gravis / Q000209:etiology* / Q000276:immunology / Q000517:prevention & control; D010446:Peptide Fragments / Q000276:immunology*; D011950:Receptors, Cholinergic / Q000276:immunology*